SGS is moving its Clinical Pharmacology Unit (CPU) to a new location in 2021, increasing its capacity to conduct Human Challenge studies.   In collaboration with University Hospital Antwerp, the company is building a new unit with a total capacity of 110 beds. This also includes a separate quarantine unit with 45 beds for CHIM studies. The move to the new unit is planned in mid-2021.   The SGS CPU has been active in early phase clinical research for 30 years, where therapeutic drugs and vaccines...